Muscle Spasm
📧 Sign up to get email alerts when something new happens for Muscle Spasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Dry Needling for Temporomandibular Disorder [NA]
A completed clinical trial evaluated dry needling for temporomandibular disorders with symptoms of Orofacial pain and muscle spasm.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm [Phase 3]
Phase 3 trial comparing etoricoxib/tizanidine against etoricoxib alone for acute low back pain with muscle spasm; the study has completed an…
-
FDA approval · 2025-08-15FDA Approved: TONMYA — Original Application (Tonix Medicines, Inc.)
FDA approved TONMYA (cyclobenzaprine hydrochloride) from Tonix Medicines, Inc. as the original NDA approval for treating muscle spasm associ…
-
FDA approval · 2025-07-30FDA Approved: ATMEKSI — Original Application (Rosemont Pharmaceuticals LLC)
FDA approved ATMEKSI (methocarbamol) from Rosemont Pharmaceuticals LLC via Original Application, providing a methocarbamol product for relie…
-
FDA approval · 2025-05-23FDA Approved: METAXALONE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Metaxalone from Amneal Pharmaceuticals of New York LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-12-17FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith Laboratories’ supplemental application for cyclobenzaprine hydrochloride, enabling changes to the product labe…
-
FDA approval · 2024-09-12FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for cyclobenzaprine hydrochloride (generic) from Rising Pharma Holdings, Inc. for relief of muscle spa…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Development and Evaluation of a Portable Wedge Device for Calf Stretching to Alleviate Strain and Spasms [NA]
Development and evaluation of a portable wedge device to stretch the calf and alleviate muscle strain and spasms are described. The trial is…
-
FDA approval · 2024-04-25FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for cyclobenzaprine hydrochloride submitted by Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2023-08-17FDA Approved: CHLORZOXAZONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Chlorzoxazone submitted by Aurobindo Pharma Limited.
-
FDA approval · 2023-08-09FDA Approved: CHLORZOXAZONE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma's original ANDA for chlorzoxazone (generic) as a muscle relaxant to relieve muscle spasm associated with acute mu…
-
FDA approval · 2023-06-12FDA Approved: METHOCARBAMOL — Original Application (FH2 PHARMA LLC)
FDA approved FH2 PHARMA LLC's original application for methocarbamol (generic) under the ANDA pathway.
-
FDA approval · 2023-04-25FDA Approved: DIAZEPAM — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for diazepam (generic) under ANDA 071583. This represents a supplemental approval for a gene…
-
FDA approval · 2023-02-09FDA Approved: METHOCARBAMOL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for methocarbamol from Aurobindo Pharma Limited.
-
FDA approval · 2023-01-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for diazepam submitted by Hikma Pharmaceuticals USA Inc., marking regulatory action to support t…
-
FDA approval · 2023-01-17FDA Approved: DIAZEPAM — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for diazepam oral solution concentrate from Chartwell RX, LLC, adding/confirming approval for this d…
-
FDA approval · 2023-01-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Diazepam from Hikma Pharmaceuticals USA Inc., indicating an update to an existing Diazepam produ…
-
FDA approval · 2023-01-13FDA Approved: VALIUM — Supplemental Application (Roche Laboratories Inc.)
The FDA approved a supplemental application for Valium (diazepam) from Roche Laboratories Inc., updating the existing NDA.
-
FDA approval · 2022-04-05FDA Approved: CHLORZOXAZONE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for chlorzoxazone (a generic muscle relaxant) from Rising Pharma Holdings, Inc.
-
FDA approval · 2021-10-20FDA Approved: CARISOPRODOL TABLETS, USP, 350 MG — Original Application (Granulation Technology, Inc.)
The FDA approved an original ANDA for Carisoprodol Tablets, USP, 350 mg, establishing a generic version of the muscle relaxant for short-ter…
-
FDA approval · 2021-07-29FDA Approved: CHLORZOXAZONE — Original Application (Happy Robin, LLC)
FDA approved a generic chlorzoxazone product under an original ANDA from Happy Robin, LLC.
-
FDA approval · 2021-02-08FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approved a supplemental application for Diazepam from Natco Pharma USA LLC (ANDA 211998). This action confirms the continued approval/av…
-
FDA approval · 2021-02-05FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for diazepam from Hikma Pharmaceuticals USA Inc. to market a generic diazepam product.
-
FDA approval · 2020-08-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for diazepam from Hikma Pharmaceuticals USA Inc., updating the approved product under the existi…
-
FDA approval · 2020-08-12FDA Approved: METHOCARBAMOL — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for methocarbamol, granting generic approval for this muscle relaxant. This…